User-Centered Design of a COPD Care Pathway for Patients With Cancer
概览
- 阶段
- 不适用
- 干预措施
- Observational Phase 1
- 疾病 / 适应症
- Chronic Obstructive Pulmonary Disease
- 发起方
- Wake Forest University Health Sciences
- 入组人数
- 101
- 试验地点
- 1
- 主要终点
- Feasibility of Designing a Novel COPD Care Pathway
- 状态
- 进行中（未招募）
- 最后更新
- 上个月
概览
简要总结
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
详细描述
Primary Objective: To design a feasible COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic. Secondary Objectives: * To identify, characterize, and explain the treatment burdens of COPD and cancer as comorbidities, as reported by patients and providers. * To identify, characterize, and explain barriers to COPD care in the oncology clinic, as reported by patients and providers. * To identify, characterize, and explain important and feasible components of COPD care for patients with cancer.
研究者
入排标准
入选标准
- •The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
- •patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
- •provider who currently works at least part-time in a medical oncology clinic or
- •provider who works at least part-time to care for patients with known or suspected COPD.
- •A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
- •Ability to understand and agree to participate on the study as described by the study information sheet.
- •Capability of speaking or reading English.
排除标准
- •Severe psychiatric symptoms; unusual social situation; or critical instability that would limit adherence to the study requirements, as determined by the study team.
研究组 & 干预措施
Observational Phase 1
Participants complete surveys
干预措施: Observational Phase 1
Observational Phase 2, Group I
Participants complete an interview and participate in a focus group on study.
干预措施: Observational Phase 2, Group I
Observational Phase 2, Group II
Participants complete an interview and participate in guided tours of the oncology clinic on study.
干预措施: Observational Phase 2, Group II
Observational Phase 3
A subset of interested participants from Phase 2 participate in a workshop on study to develop a final draft of the COPD care pathway.
干预措施: Observational Phase 3
结局指标
主要结局
Feasibility of Designing a Novel COPD Care Pathway
时间窗: Up to 60 days
The feasibility of designing a novel COPD care pathway for patients with cancer that is responsive to mixed methods data by specifically addressing (i) the reduction of treatment burden of patients, (ii) the implementation of important and feasible components of COPD care, and (iii) the adaptation necessary to overcome common barriers to COPD care in the community oncology clinic, with feasibility defined by the agreement of a supermajority of stakeholders at a design team workshop.
次要结局
- Identifying Important and Feasible Components of COPD Care - Best Practices for Cancer Patients(Up to 4 months)
- Number of Treatment Burdens Identified(Up to 4 months)
- Number of Barriers to COPD Care in Oncology Clinics(Up to 4 months)